Discontinuation for Oral Anticoagulants in Patients With Atrial Fibrillation

Hospital Italiano de Buenos Aires

Status: Unknown

Conditions: Auricular Fibrillation; Anticoagulant Drugs

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT04133545

Protocol_3525

Details and patient eligibility

About

The purpose of this study is to compare the discontinuation rates for vitamin K antagonists and for direct oral anticoagulants during their first year

Full description

The purpose of this study is to compare the discontinuation rates for vitamin K antagonists and for direct oral anticoagulants during their first year of use after their initiation during hospitalization in patients covered by our health insurance plan.

Enrollment: 360 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Patient older than 18 years of age covered by our Health Care Insurance Plan.
2. Indication for oral anticoagulation with an expected duration of use of no less than 1 year.

Exclusion criteria

1. Refusal to take part.
2. Use of oral anticoagulants within 6 months prior to admission.
3. Presence of mechanical prosthetic valve.
4. Chronic renal failure with creatinine clearance <30 mL/min (estimated using the MDRD formula).

Trial design

360 participants in 2 patient groups

DOAC

Description:

Direct oral anticoagulant

OAC

Description:

Vitamin K anticoagulant